Cytalux for finding cancer during surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a dye called Cytalux that helps surgeons see cancer during surgery. You get the dye before surgery, and it makes cancer cells glow under a special light. This could help doctors remove more cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cancer in your digestive system, pancreas, liver, bile ducts, esophagus, or a gynecologic cancer that needs a special type of surgery called HIPEC or debulking.
- You are scheduled for surgery to remove a tumor or to look at how far the cancer has spread using a camera in your belly.
- You agree to stop taking folic acid, folate, or any supplements with folate for 2 days before getting the study dye.
- You or your legal guardian can sign a consent form to join the study.
- You do not have a history of severe allergic reactions to indocyanine green or any part of the study dye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.
This trial tests if a special dye called indocyanine green can help surgeons find sentinel lymph nodes during surgery for esophageal cancer. It may help doctors know which lymph nodes to remove for better staging.
This study tests whether a special fluorescent camera during surgery can help surgeons better operate on resectable (removable) stomach or esophagus cancer. It may help improve how surgery is guided, with the goal of safer and more accurate tumor removal.
This trial tests a dye called Cytalux (pafolacianine) to help surgeons see cancer during lung or ovarian cancer surgery. If you are scheduled for surgery to remove lung cancer or to debulk ovarian cancer, you may be eligible.
This trial tests a dye (CYTALUX) that helps surgeons see endometrial cancer during surgery. You may be eligible if you have endometrial cancer and are scheduled for surgery.
This study tests a special dye, called pafolacianine, that is injected before surgery to help surgeons see hidden cancer spots in the belly during the operation. The goal is to see if using this dye improves how completely the cancer is removed in people with gastrointestinal cancer that has spread to the belly lining.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.